TKI resistance markers found for NSCLC patients

Korean scientists have identified several genetic markers that may explain lack of response to tyrosine kinase inhibitor therapy in patients with epidermal growth factor receptor-activating, non-small-cell lung cancer.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news